Results

Total Results: 2,080 records

Showing results for "drug".

1601. #14 SUBSTANCE ABUSE (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
      December 01, 2015 - Recent marketing data collected by the FDA’s Center for Drug Evaluation and Research indicates that … The drug potentially holds additional promise as an AUD therapy because its safety profile is better … Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs. … Mobile medical applications: guidance for industry and Food and Drug Administration staff. … Food and Drug Administration (FDA); 2015 Feb 9. 44 p.

1602. Systematic-Review-Integration White-Paper (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/systematic-review-integration_white-paper.pdf
      June 01, 2014 - Food and Drug Administration trials, representing work from systematic reviewers that would be very

1603. Radiation Therapy for Brain Metastases: A Systematic Review | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/radiation-brain-metastases/protocol
      January 28, 2020 - Combining whole brain radiotherapy with target drug for non-small cell lung cancer with multiple brain … Food and Drug Administration. What is a Serious Adverse Event?  Accessed on October 10, 2019.

1604. Fatty-Acids-Cardiovascular-Disease Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
      April 02, 2015 - Evidence-based Practice Center Systematic Review Protocol Project Title: Omega 3 Fatty Acids and Cardiovascular Disease -- Update I. Background and Objectives for the Systematic Review The Office of Dietary Supplements (ODS), the National Institutes of Health (NIH), has a long history of commissioning AHRQ-based…

1605. Research Protocol: Radiation Therapy for Brain Metastases (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
      October 10, 2019 - Combining whole brain radiotherapy with target drug for non-small cell lung cancer with multiple brain … Food and Drug Administration. What is a Serious Adverse Event?

1606. Disposition of Comments for CER 183 Tonsillectomy for OSDB (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
      January 17, 2017 - perioperative use of opioids; however, our KQ did not address perioperative opioid use given US Food and Drug … published before 2000 and thus not eligible for inclusion in the current review, in which we addressed drug

1607. Disposition of Comments for CER 181 Mental Health Care (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-children_disposition-comments.pdf
      December 19, 2016 - criteria, such as delivery of care to children with developmental disorders only, and settings such as drug … TEP 6 General Second, the authors list an exclusion criteria of “Interventions targeting only… drug

1608. Hepatic-Fibrosis White-Paper (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatic-fibrosis_white-paper.pdf
      April 01, 2014 - Strategies for obtaining unpublished drug trial data: a qualitative interview study. … Progression of liver fibrosis among injection drug users with chronic hepatitis C. … Progression of liver fibrosis among injection drug users with chronic hepatitis C.

1609. Behavioral Programs for Diabetes Mellitus (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
      September 11, 2015 - Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and

1610. 2020 EPC Program Year in Review | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/news/2020-year-in-review
      January 01, 2020 - Home » News » 2020 EPC Program Year in Review 2020 EPC Program Year in Review Download 2020 EPC Year in Review (PDF, 515 KB). EPC Mission: Transform healthcare by increasing the quality, availability, and use of evidence via scientifically rigorous and unbiased anal…

1611. EHC Research Protocol: Documentation Burden (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/documentation-burden-protocol.pdf
      July 26, 2023 - Food and Drug Administration, ClinicalTrials.gov, Health Canada, U.K.

1612. Meeting Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
      January 01, 2011 - Network: www.researchadvocacy.org – Roadmap to Research Advocacy – Advocate Institute • Food and Drug

1613. Evaluation of Mental Health Applications (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-app-protocol-updated.pdf
      January 01, 2018 - substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug

1614. C- Evidence-based Practice Center Technical Brief Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
      August 05, 2010 - What is the current the Food and Drug Administration (FDA) clearance status of these positional MRI

1615. Vte-Prophyalaxis Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
      May 01, 2013 - This drug also has the potential for off-label use in other patient populations. … Abstract Review Level* No original data = 4,150 Does not evaluate a population of interest = 1,401 Drug … conducted in humans = 6 Does not evaluate a population of interest = 976 Treatment of VTE = 135 Comparator drug

1616. AHRQ Slide Template
      effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
      March 01, 2022 - Patient: Adults with episodic migraine Intervention: Systemic opioid abortive therapy, nonopioid abortive drug

1617. Telehealth for Women | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/telehealth-women/protocol
      September 20, 2021 - Food and Drug Administration; HDI = human development index rating; KQ = key question; RCT = randomized

1618. Telehealth for Women (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/telehealth-women-protocol.pdf
      June 21, 2021 - Food and Drug Administration; HDI = human development index rating; KQ = key question; RCT = randomized

1619. Cervical Degenerative Disease Treatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cervical-degenerative-protocol.pdf
      January 12, 2022 - 22 RCT hedge (sensitive) ((((((((groups[tiab])) OR (trial[tiab])) OR (randomly[tiab])) OR (drug

1620. Cervical Ripening in the Outpatient Setting (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
      December 18, 2019 - Disease Control and Prevention CR Cervical ripening EPC Evidence-based Practice Center FDA Federal Drug